Conjecture
发表于 2025-3-21 16:27:15
书目名称Chemoradiation in Cancer Therapy影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0224930<br><br> <br><br>书目名称Chemoradiation in Cancer Therapy读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0224930<br><br> <br><br>
起波澜
发表于 2025-3-21 22:03:27
http://reply.papertrans.cn/23/2250/224930/224930_2.png
灰姑娘
发表于 2025-3-22 03:00:21
http://reply.papertrans.cn/23/2250/224930/224930_3.png
reflection
发表于 2025-3-22 06:34:04
http://reply.papertrans.cn/23/2250/224930/224930_4.png
五行打油诗
发表于 2025-3-22 09:20:07
http://reply.papertrans.cn/23/2250/224930/224930_5.png
Indicative
发表于 2025-3-22 14:39:29
The Role of Gemcitabine in Combined Modality Therapyon in pancreatic carcinoma, gemcitabine has been licensed for the treatment of nonsmall-cell lung cancer (NSCLC) .. The focus of this chapter will be to examine the current preclinical and clinical evidence probing the efficacy of gemcitabine as a clinically useful radiosensitizing agent. It will be
Indicative
发表于 2025-3-22 17:47:45
http://reply.papertrans.cn/23/2250/224930/224930_7.png
勤勉
发表于 2025-3-23 01:13:48
Combined Modality Strategies in the Treatment of Head and Neck Cancerr Society estimates that in the United States alone approx 40,300 new cases of HNC will be diagnosed annually with approx 11,700 deaths associated from this disease .. If cured, HNC patients are at increased risk of developing a second malignancy, estimated to occur at an annual incidence of 3–7% (3
Traumatic-Grief
发表于 2025-3-23 01:53:39
The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer 131,000 new cases of nonsmall-cell lung cancer (NSCLC) diagnosed in 2000 will die from their disease .. The focus of this chapter is on the patients who present with locally advanced or stage III NSCLC (about 46,000 patients yearly). Although it is tempting to think of stage III NSCLC as a uniform
半身雕像
发表于 2025-3-23 07:37:28
http://reply.papertrans.cn/23/2250/224930/224930_10.png